Raising the Bar

05/31/2016

Glenn Welling, Christopher Hetrick and Brendan Springstubb of Engaged Capital describe how they distinguish themselves from bigger-name activists, the “disease” they often look to cure at target companies, a key goal they have beyond earning great returns, and why they see mispriced value in Benchmark Electronics, Rovi, Outerwall, Medifast and Jamba.


If you are a subscriber, log in to access the issue and bonus archive:


Not a subscriber? Subscribe today!